Skip to main content

Corporate insider profile

Kamal Adawi Insider Trades

Kamal Adawi has reported no open-market purchases on SEC Form 4 and is a net seller of $13,525 across 1 company. The most recent open-market transaction was reported on Nov 3, 2026. Source: SEC Form 4 filings.

Latest reported as Chief Financial Officer of FATE THERAPEUTICS INC (FATE).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$13,524.69
Latest transaction
Nov 3, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 3, 2026FATE THERAPEUTICS INC (FATE)Chief Financial OfficerSale6,582$2.05$13,525

Common questions

Kamal Adawi insider trading FAQ

Is Kamal Adawi buying or selling stock?
Across all SEC Form 4 open-market filings on record, Kamal Adawi is a net seller of $13,525, with no open-market purchases reported. The latest transaction was reported on Nov 3, 2026.
Which companies does Kamal Adawi report insider trades for?
Kamal Adawi has reported open-market trades in FATE THERAPEUTICS INC (FATE). The latest SEC-reported relationship is Chief Financial Officer of FATE THERAPEUTICS INC (FATE).
Where does Kamal Adawi's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1788393, and refreshes this page daily.